USE OF A COMBINATION CONTAINING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) WITH AN INHIBITOR OF CYTOCHROME P450, SUCH AS PROTEASE INHIBITORS

Details for Australian Patent Application No. 2003296647 (hide)

Owner BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Inventors Cordingley, Michael Graham

Agent Davies Collison Cave

Pub. Number AU-A-2003296647

PCT Number PCT/EP2003/0142

PCT Pub. Number WO2004/054586

Priority 60/433,690 16.12.02 US

Filing date 15 December 2003

Wipo publication date 9 July 2004

International Classifications

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/00

A61K 031/427 - not condensed and containing further heterocyclic rings

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/433,690 16.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003296647

9 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003296648-METHOD FOR LOCATING LIGANDS BONDING TO A DRUG TARGET BY MEANS OF NMR DISPLACEMENT EXPERIMENTS

2003296646-ABSAUGVORRICHTUNG